TNFRSF9 and lymphoma: In addition, human NK cells were found to consistently up-regulate 4-1BB when exposed to rituximab-coated autologous lymphoma cells (127), providing the rationale to explore the combination of anti-4-1BB and -CD20 mAbs in the clinical setting.